Sexual & Reproductive Health
Drug developer announces results of treatment of female sexual arousal disorder
Published in Women's Health Weekly, June 23rd, 2005
The multicenter study was randomized, double-blind, placebo-controlled, and designed to investigate the efficacy and safety of three strengths of the Femprox cream in premenopausal and post-menopausal women diagnosed with female sexual arousal disorder (FSAD).
Femprox is applied topically and incorporates alprostadil, a vasodilator, with the NexACT permeation technology. The results were announced at the annual meeting of the American Urological Association.
The patients, who were between the ages of 21 and 65, were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Long-term passive smoking exposure may increase risk in premenopausal women - Health Behaviors
Nondieters more successful at boosting health than dieters, study finds - Obstetrics
Transvaginal ultrasonography accurately detects ectopic pregnancy - Osteoporosis
Black women have lower fracture risk at all BMD levels than white women - Uterine Leiomyoma
Daily ganirelix treatment reduces volume of uterus and fibroids - Addiction Medicine
Over 4% of pregnant women used illicit drugs in past month - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
